Sign in to continue:

Friday, February 20th, 2026

TrickleStar Receives SGX-ST Approval for Up to 67.4 Million Rights Shares Issuance








TrickleStar Secures Key Approval for Rights Issue – Potential Share Price Catalyst

TrickleStar Secures Key Approval for Rights Issue – Potential Share Price Catalyst

TrickleStar Limited, a Singapore-incorporated company, has achieved a significant milestone in its proposed renounceable non-underwritten rights issue. The company announced on 6 January 2025 that it has received the Listing and Quotation Notice (LQN) from the Singapore Exchange Securities Trading Limited (SGX-ST) for the listing and quotation of up to 67,426,073 Rights Shares, subject to compliance with SGX-ST’s listing requirements.

Key Details for Shareholders

  • The LQN permits TrickleStar to proceed with the listing and quotation of the Rights Shares tied to the proposed rights issue.
  • The rights issue is renounceable and non-underwritten, meaning shareholders can transfer their rights but the issue is not backed by an underwriter.
  • The LQN is not an endorsement of the merits of the rights issue, the Rights Shares, the company, or its securities.
  • Further announcements on the rights issue will be made as developments arise.

Potential Impact on Share Price

While the receipt of the LQN is a procedural step, it could potentially influence TrickleStar’s stock valuation. Investors might view this development as a signal of progress in the company’s capital-raising efforts. However, the actual impact on share price will depend on market sentiment and further disclosures about the rights issue, including pricing and terms.

Important Notes for Investors

The announcement was reviewed by TrickleStar’s sponsor, PrimePartners Corporate Finance Pte. Ltd., but it is important to note that the SGX-ST has not examined or approved the announcement. This caveat underscores the need for investors to exercise due diligence when considering the implications of the rights issue.

For further information, shareholders may contact PrimePartners Corporate Finance Pte. Ltd. via the details provided in the announcement (16 Collyer Quay, #10-00 Collyer Quay Centre, Singapore 049318, [email protected]).

Disclaimer: This article is for informational purposes only and does not constitute financial advice. Investors should consult their financial advisors before making any investment decisions. The views expressed are based on the announcement dated 6 January 2025 and are subject to change as further details emerge.




View TrickleStar Historical chart here



Independent Auditor’s Report for Camsing Healthcare Limited FY2025 – Qualified Opinion, Key Audit Matters & Dividend Information

Camsing Healthcare Limited: FY2025 Independent Auditor’s Report Analysis Camsing Healthcare Limited’s annual report for FY2025 provides a comprehensive overview of the Group’s financial standing, operational performance, and risks. This analysis draws directly from the...

Medi Lifestyle Limited EGM 2025: Approval of Debt Conversion, Change of Controlling Shareholder, and New Constitution Adoption

Medi Lifestyle Extraordinary General Meeting: Key Highlights and Investor Takeaways Medi Lifestyle Limited EGM: Major Debt Conversion and Control Changes Approved Date of Meeting: 22 December 2025 Location: 1 Robinson Road, #21-01 AIA Tower,...

Daiwa House Logistics Trust 3Q FY2025 Business Update: Portfolio Performance, Financials & Market Outlook

Daiwa House Logistics Trust 3Q FY2025: Detailed Investor Update Daiwa House Logistics Trust Reports 3Q FY2025 Business Update: Key Details for Investors Summary of Key Financial and Operational Highlights Portfolio Occupancy: 92.0% as at...

   Ad